...
首页> 外文期刊>Journal of neurosurgery. >The long-term significance of microscopic dural invasion in 354 patients with pituitary adenomas treated with transsphenoidal surgery.
【24h】

The long-term significance of microscopic dural invasion in 354 patients with pituitary adenomas treated with transsphenoidal surgery.

机译:经蝶窦手术治疗的354例垂体腺瘤患者显微硬脑膜浸润的长期意义。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECT: Pituitary adenomas are considered benign tumors; however, they may infiltrate surrounding tissues including the dura mater. In this paper the authors analyze the clinical significance of microscopically confirmed dural invasion by comparing a range of variables (age and sex of patients, adenoma type, adenoma size on magnetic resonance [MR] images, remission, residual pituitary disease, recurrence, survival, and disease-free interval after surgery) between patients with noninvasive adenomas and those with invasive ones. METHODS: Between 1992 and 1997 dural specimens were obtained in 354 patients with pituitary adenomas who underwent transsphenoidal surgery performed by the senior author (E.R.L.). Dural specimens were examined using routine histological methods and assessed for invasion by pituitary adenoma tissue. The dura was invaded by the pituitary adenoma in 161 patients (45.5%), and in 192 patients (54.5%) no evidence of dural invasion was found. Dural invasion was present significantly more frequently in the repeated surgery group (69%, 55 patients) than in the primary transsphenoidal surgery group (41%, 291 patients). The mean age of patients undergoing primary transsphenoidal surgery was significantly older in cases of invasive adenomas (50 years) compared with cases of noninvasive adenomas (43 years), and these age differences also correlated with adenoma size. Women tend to develop clinically evident, smaller adenomas at a younger age than men. Of the patients with pituitary adenomas that were 20 mm or smaller, 117 (76%) of 154 were women, whereas of the patients with adenomas that were larger than 20 mm, 74 (54%) of 137 were men. The frequency of dural invasion increased with increasing size of the pituitary adenoma as measured on MR images. In 291 patients who underwent primary pituitary surgery, the frequency of dural invasion according to adenoma size was 24% (< or = 10 mm), 35% (> 10 to < or = 20 mm), 55% (> 20 to < or = 40 mm), and 70% (> 40 mm). In patients who underwent primary transsphenoidal surgery, dural invasion was present in more than 50% of those with nonfunctioning adenomas and in 30 to 35% of patients with endocrinologically active adenomas. The mean diameter of the gonadotrophic adenomas and null-cell adenomas was significantly larger than that of each of the endocrinologically active adenomas. In 58 (20%) of 291 patients who underwent primary pituitary surgery there was residual pituitary disease postsurgery, and 20% of this subset of patients showed clinical improvement to such an extent that no further management was recommended. After pituitary surgery, residual tumor tissue was demonstrable significantly more frequently in patients with invasive adenomas than in those with noninvasive adenomas. Recurrences after initial remission (cure) of pituitary disease occurred in 18 (8.8%) of 205 patients between 2 and 79 months after primary pituitary surgery (median 25 months). The recurrence rate was not related to dural invasion in a consistent or significant fashion. Seven patients died between 14 and 79 months after pituitary surgery and all had invasive adenomas identified on gross observation at surgery and on microscopy. The survival rate was slightly but significantly decreased for patients with invasive adenomas (91%) compared with patients with noninvasive adenomas (100%) at 6 years postsurgery. CONCLUSIONS: The principal significance of dural invasion by pituitary adenoma is the persistence of tumor tissue after transsphenoidal surgery (incomplete adenomectomy; 20% in primary pituitary tumor resections). The increase in adenoma size with time and the concurrent development of dural invasion are the major factors that determine an incomplete adenomectomy. When the adenoma remains restricted to the sellar compartment or shows only moderate suprasellar extension, dural invasion may not yet have developed and conditions for complete selective adenomectomy are improved.
机译:目的:垂体腺瘤被认为是良性肿瘤。但是,它们可能会渗入包括硬脑膜在内的周围组织。本文作者通过比较一系列变量(患者的年龄和性别,腺瘤类型,核磁共振图像上的腺瘤大小,缓解,残余垂体疾病,复发,生存率,无创性腺瘤患者与有创性腺瘤患者之间的差异)。方法:在1992年至1997年之间,从354位垂体腺瘤患者中获得了硬脑膜标本,这些患者接受了资深作者(E.R.L.)的经蝶骨手术。使用常规组织学方法检查硬脑膜标本并评估垂体腺瘤组织的侵袭性。垂体腺瘤侵犯硬脑膜161例(45.5%),而192例(54.5%)未发现硬脑膜浸润的证据。重复手术组(69%,55例患者)比初次经蝶窦手术组(41%,291例患者)出现硬脑膜侵袭的频率更高。侵入性腺瘤病例(50岁)与非侵入性腺瘤病例(43岁)相比,进行初次经蝶窦手术的患者的平均年龄明显更高,并且这些年龄差异也与腺瘤的大小有关。女性往往比男性年轻时发展出临床上明显的,较小的腺瘤。垂体腺瘤小于或等于20毫米的患者中,女性为154人中的117人(占76%),而腺瘤大于20毫米的患者中,男性为137人中的74人(占54%)。硬脑膜浸润的频率随着垂体腺瘤大小的增加而增加,如在MR图像上测量的。在291例行垂体手术的患者中,根据腺瘤大小,硬脑膜浸润的发生率分别为24%(<或= 10 mm),35%(> 10到<或= 20 mm),55%(> 20到 40毫米)。在接受初次经蝶窦手术的患者中,超过50%的无功能腺瘤患者和30%至35%的具有内分泌活性腺瘤的患者存在硬脑膜浸润。性腺营养腺瘤和空细胞腺瘤的平均直径明显大于每个内分泌活性腺瘤的平均直径。在291例行脑垂体手术的患者中,有58例(20%)存在残留的垂体疾病术后手术,其中20%的患者表现出一定程度的临床改善,因此不建议进一步治疗。垂体手术后,浸润性腺瘤患者比非浸润性腺瘤患者更容易发现残余肿瘤组织。 205例初次垂体手术后2至79个月(中位25个月)的患者中,有18例(8.8%)发生了垂体疾病初次缓解(治愈)后的复发。复发率与硬脑膜浸润的持续性或显着性无关。垂体手术后14到79个月之间有7例患者死亡,并且在手术时进行肉眼观察和显微镜检查均发现了浸润性腺瘤。术后6年,浸润性腺瘤患者的生存率略有下降,但显着降低(91%)。结论:垂体腺瘤硬脑膜浸润的主要意义是经蝶窦手术(不完全腺瘤切除;垂体原发性肿瘤切除术占20%)后肿瘤组织的持久性。腺瘤大小随时间的增加以及硬脑膜侵犯的同时发展是决定腺瘤切除术不完全的主要因素。当腺瘤仍然局限于鞍腔或仅显示中度鞍上延伸时,可能尚未出现硬脑膜浸润,完全选择性腺切除术的条件得到改善。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号